Global proteomics in MM.1S treated with pomalidomide or dipeptides

ABSTRACT: Global proteomics of Multiple Myeloma cell line MM.1S treated with pomalidomide or cyclic imide dipeptides for 10 h. The samples were labeled with TMT-16pro.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Suspension Culture

SUBMITTER: Christina Woo  

LAB HEAD: Christina Woo

PROVIDER: PXD025336 | Pride | 2022-07-28

REPOSITORIES: Pride